Sapio Sciences and Ultima Genomics have announced a strategic partnership aimed at accelerating multi-omics research by providing a unified, end-to-end solution. The collaboration will integrate Sapio's AI-powered lab informatics platform with Ultima Genomics' high-throughput, low-cost sequencing technology. This partnership seeks to make complex multi-omics workflows, which combine data from different biological layers like DNA and the epigenome, more accessible and efficient for researchers. Traditionally, this type of deep analysis has been expensive and fragmented, requiring multiple assays and disjointed workflows. By combining Ultima's data generation capabilities with Sapio's analytics, automation, and data management tools, the new solution will create a seamless, unified environment.

The collaboration is expected to provide key benefits for customers, including lower costs per sample, faster discovery cycles, and improved traceability for compliance. This is achieved by removing workflow complexity and allowing researchers to manage multi-omics data more effectively, ultimately accelerating the process of gaining insights. According to Gilad Almogy, CEO of Ultima Genomics, the partnership aligns with the company's goal of making genomic information more scalable and empowering organizations to leverage AI-powered insights. Andrew Wyatt, Chief Growth Officer at Sapio Sciences, noted that the partnership gives Ultima's customers a direct path to combining world-class sequencing with equally powerful informatics, simplifying lab operations and ensuring quality and compliance. The partnership is part of the Sapio Sciences Partner Program, which works with technology, services, and reseller partners to create integrated solutions for customers.